Back to Vident Advisory, LLC Vident Advisory, LLC

MRNAMRNA

6 quarters

Position history for Vident Advisory, LLCVident Advisory, LLC's holdings in Moderna, Inc.

Yes. Vident Advisory holds 6,613 shares of MRNA (Moderna), worth $463,109, as of its Q2 2026 13F filing. It reduced the position by 1,175 shares (-15.1%) from Q1 2026. Vident Advisory has held MRNA since Q1 2026, across 2 quarterly 13F filings.

Current Value

$463,109

Current Shares

6,613

Total Value Change

-$100,799

Total Shares Change

-1,825

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6,613
-15.1%
$463,1090.0%$70.03
0
2026-Q1
New
7,788
—
$395,6310.0%$50.80
33
2025-Q3
Exited
0
-100.0%
$00.0%$25.83
0
2025-Q2
New
7,468
—
$206,0420.0%$27.59
32
2024-Q4
Exited
0
-100.0%
$00.0%$41.58
0
2024-Q3
New
8,438
—
$563,9080.0%$65.75
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used